Navigation Links
DermaGen AB Receives Over 1 Million Euros From a New Share Issue
Date:4/2/2008

LUND, Sweden, April 2 /PRNewswire/ -- DermaGen AB today announced a cash injection from Midroc New Technology AB who now joins existing owners, Karolinska Development and Ostersjostiftelsen. The capital will be used for the further development of DermaGen's first candidate drug. The majority will be used to initiate a clinical phase 2a study in patients with Atopic Dermatitis (AD), for which the company has already received approval, and to further develop the company's R & D pipeline.

"We are pleased that the company has attracted a new investor. Both Karolinska Development and Ostersjostiftelsen continue to invest, reinforcing the financial strength of the company and enabling us to carry out a clinical trial with DPK-060. This is a novel antimicrobial treatment for AD, and our lead antimicrobial candidate for topical use, it will be tested in a phase 2a study in patients during 2008," says Jan Alenfall, CEO of DermaGen.

The move towards clinical activities marks a new phase for DermaGen and new members of the board of directors have been appointed to support this.

Jonas Frick, CEO Resistentia AB, was elected as Chairman of the Board of Directors at the annual meeting on the 31st of March. "DermaGen is a very exciting company and I am looking forward to contributing to the successful development of DermaGen's novel treatment options," says Jonas Frick.

Goran Linder, CEO of Midroc New Technology will also become member of DermaGen's Board of Directors. "As a pharmaceutical research company, DermaGen represents a new type of investment focus for Midroc New Technology, we see this as an extremely exciting new opportunity," says Goran Linder, CEO of Midroc New Technology.

Global sales of anti-infective drugs reached $44.5 billion in 2005 and will likely double over the next 5 years. Worldwide sales of products used in AD therapy are growing rapidly due to the increasing prevalence of the disease and are expected to reach $2 bi
'/>"/>

SOURCE DermaGen AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
2. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
3. Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
4. Florastor(R) Receives ConsumerLab.com Certification
5. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
6. Vermillion Receives Award From the Society of Gynecologic Oncologists
7. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
8. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
9. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März 2015 /PRNewswire/ ... und das deutsche biopharmazeutische Unternehmen CureVac geben ... Euro (52 Millionen US-Dollar) in CureVac investiert. ... medizinisch angewandten Messenger-RNA (mRNA). Auf Basis dieses ... Behandlung von Krankheiten und zum Schutz vor ...
(Date:3/5/2015)... , March 5, 2015 Bayer HealthCare announced ... the Conquer Cancer Foundation of the American Society of ... health information technology platform designed to unlock vast quantities ... cancer.  "Bayer is proud to join ... to leverage Big Data to help people whose lives ...
(Date:3/5/2015)...  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, ... automated DNA-based molecular analyses, announces that it is ... utilizes cutting edge technology, including next- generation DNA ... women are diagnosed with cervical cancer in ... Papillomaviruses (HPV) are a group of more than ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... and LOS ANGELES , July 21 /PRNewswire-Asia/ ... or,the "Company"), one of the leading health products distribution and ... of seven new chain,drugstores in July. These new openings ... City, 31 in Baishan City, and a total of ...
... CHARLOTTE, N.C. , July 21 /PRNewswire-FirstCall / -- ... has completed the acquisition of the Anhydro business, a Soeborg, ... and dewatering plants and equipment.  The terms of the transaction were ... , ...
Cached Medicine Technology:China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 2China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 3China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 4SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a ... repair market, reported record revenue of $4.79 million for ... $2.98 million in the year-ago fourth quarter demonstrating the ... “Our strong fourth quarter revenue growth reflects the market’s ... is driving increased surgeon adoption of our unique product ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support ... on their nutrition CEUs. To raise awareness ... HomeCEUConnection.com is offering 10% off selected nutrition ... NUTRITION2015 . , High Quality Continuing Education ... high-quality continuing education courses for Physical Therapists, ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading ... health management arena, is pleased to announce a webinar ... Advanced Care™ (ACUITY) version 7.20. The session will focus ... advantages of automation. , The webinar, scheduled for March ... by Jeff Frater, RN, BSN, Director of Partner Development ...
(Date:3/5/2015)... Portland, Ore. (PRWEB) March 05, 2015 ... health sciences university founded in 1904, has launched ... behaviors and positive lifestyle changes. The Northwest Center ... educate health professionals, support community outreach, and conduct ... promotion, functional medicine, diet and nutrition. The center ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 INTEGRATED ... healthcare organizations to participate in its 2015 Children’s ... from executive and director-level positions, and the survey ... Last year’s report featured data on 60 executive ... children’s healthcare organizations and 7 subsidiary children’s hospitals. ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... Reinberg HealthDay Reporter , TUESDAY, Nov. 30 (HealthDay News) ... more vitamin D, a new report from the Institute of Medicine ... day. The IOM did bump up the recommended dietary ... report, released 13 years ago. , , For many people, 600 ...
... (HealthDay News) -- Early assessment of rheumatoid arthritis can ... likelihood of disease remission without having to take disease-modifying ... Although DMARDs are considered effective in treating rheumatoid arthritis, ... linked to uncommon but serious side effects. The ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... model, researchers say they,ve determined that relying on "active ... a "reasonable approach" and alternative to immediate treatment, which ... impotence. If the tumor were to start growing ...
... American Society of Hematology (ASH) recognizes the following abstract ... in Orlando, FL, with the highest scoring abstracts in ... resident physician, and post-doctoral fellow. Merit Award winners receive ... The 2010 Merit Award recipients are: ...
... In what might be one of the world,s first ... that they have successfully implanted an experimental device in the ... control his ability to swallow. The device, which could offer ... problems, is controlled by pulling on a tiny metal pin ...
... Nov. 30, 2010 The latest episode in the ... Challenges/Chemistry Solutions ," focuses on the discovery that black ... is the staple food for one-third of the world,s ... allergies, asthma and other diseases. In the ...
Cached Medicine News:Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 2Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 3Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 4Health News:Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 3Health News:ASH announces 2010 merit award winners 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 3
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Enhanced features including aspiration holes and ... laparoscopic procedures requiring precise dissection with ... increased suction demands. ,Flexible design ... and nonretractable electrodes and multiple tip ...
... including aspiration holes and additional electrode ... requiring precise dissection with decreased risk ... demands. ,Flexible design options allow ... electrodes and multiple tip designs. Optimize ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: